Martin D E, Goldman M P
University of California, San Diego.
J Dermatol Surg Oncol. 1990 Jan;16(1):18-22. doi: 10.1111/j.1524-4725.1990.tb00003.x.
The dorsal marginal rabbit ear vein was injected with 0.25 ml of 0.1% or 0.25% sodium tetradecyl sulfate (STS) (Sotradecol Injection) or undiluted or 50% Scleremo (Scl) (chromated glycerin). Only the 50% Scl solution failed to produce clinical or histologic thrombosis at 1 hour. Clinical fading was observed in STS-treated vessels at 10 days postinjection. Histologically, early thrombus formation with focal endothelial necrosis was replaced by fibrosis and microangiopathic recanalization. Although undiluted Scl caused similar, yet milder histologic findings, luminal recanalization after 10 days resulted in a clinically unfaded vessel. The use of 50% Scl produced no endothelial damage with no subsequent change in vessel appearance. Cutaneous necrosis or extravasation of erythrocytes was not observed.
将0.25毫升0.1%或0.25%的十四烷基硫酸钠(STS)(十四烷基硫酸钠注射液)或未稀释的或50%的硬化剂(Scl)(铬化甘油)注入兔耳背侧边缘静脉。仅50%的Scl溶液在1小时时未产生临床或组织学血栓形成。注射后10天,在接受STS治疗的血管中观察到临床褪色。组织学上,早期血栓形成伴局灶性内皮坏死被纤维化和微血管再通所取代。尽管未稀释的Scl引起了类似但较轻的组织学表现,但10天后管腔再通导致血管临床未褪色。使用50%的Scl未造成内皮损伤,血管外观随后也无变化。未观察到皮肤坏死或红细胞外渗。